Skip to main content

Mercaptopurine Tablets Shortage

Last Updated: March 27, 2025
Status: Current

Products Affected - Description
    • Mercaptopurine tablet, Hikma, 50 mg, bottle, 25 count, NDC 00054-4581-11
    • Mercaptopurine tablet, Hikma, 50 mg, bottle, 250 count, NDC 00054-4581-27
    • Mercaptopurine tablet, Mylan (Viatris), 50 mg, bottle, 25 count, NDC 00378-3547-52 - discontinued
    • Mercaptopurine tablet, Mylan (Viatris), 50 mg, bottle, 250 count, NDC 00378-3547-25 - discontinued
    • Mercaptopurine tablet, Quinn Pharmaceuticals, 50 mg, bottle, 25 count, NDC 69076-0913-02
    • Mercaptopurine tablet, Quinn Pharmaceuticals, 50 mg, bottle, 250 count, NDC 69076-0913-25
Reason for the Shortage
    • Hikma did not provide a reason for the shortage.
    • Viatris discontinued mercaptopurine 50 mg tablets in 25 count bottles in March 2025.
    • Quinn has mercaptopurine tablets on shortage due to manufacturing issues. The company has temporarily discontinued mercaptopurine 50 mg tablets.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Hikma has mercaptopurine 50 mg tablets in 25 count and 250 count bottles on allocation.
    • Quinn has temporarily discontinued mercaptopurine 50 mg tablets in 25 count and 250 count bottles and the company cannot estimate a release date.

Updated

Updated March 27, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 8, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.